Atrial Flow Regulator for Postcapillary Pulmonary Hypertension : First-in-Human Transcatheter AFR Device Implantations in RCM
© 2022 The Authors..
Restrictive cardiomyopathy (RCM) has a poor prognosis and limited treatment options apart from heart transplantation (HTx). We report on the first-in-human interventional atrial flow regulator (AFR) implantations in 3 children with RCM, leading to marked clinical and hemodynamic improvement. We propose the AFR as bridge to HTx or destination therapy in RCM. (Level of Difficulty: Advanced.).
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:4 |
---|---|
Enthalten in: |
JACC. Case reports - 4(2022), 14 vom: 20. Juli, Seite 878-884 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Hansmann, Georg [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Revised 02.08.2022 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.1016/j.jaccas.2022.05.010 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM344320189 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM344320189 | ||
003 | DE-627 | ||
005 | 20231226022508.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.jaccas.2022.05.010 |2 doi | |
028 | 5 | 2 | |a pubmed24n1147.xml |
035 | |a (DE-627)NLM344320189 | ||
035 | |a (NLM)35912333 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Hansmann, Georg |e verfasserin |4 aut | |
245 | 1 | 0 | |a Atrial Flow Regulator for Postcapillary Pulmonary Hypertension |b First-in-Human Transcatheter AFR Device Implantations in RCM |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 02.08.2022 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a © 2022 The Authors. | ||
520 | |a Restrictive cardiomyopathy (RCM) has a poor prognosis and limited treatment options apart from heart transplantation (HTx). We report on the first-in-human interventional atrial flow regulator (AFR) implantations in 3 children with RCM, leading to marked clinical and hemodynamic improvement. We propose the AFR as bridge to HTx or destination therapy in RCM. (Level of Difficulty: Advanced.) | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a AFR, atrial flow regulator | |
650 | 4 | |a HF, heart failure | |
650 | 4 | |a HFpEF, heart failure with preserved ejection fraction | |
650 | 4 | |a HTx, heart transplantation | |
650 | 4 | |a LA, left atrium | |
650 | 4 | |a LAP, left atrial pressure | |
650 | 4 | |a LV, left ventricle | |
650 | 4 | |a LVEDP, left ventricular end-diastolic pressure | |
650 | 4 | |a MR, magnetic resonance | |
650 | 4 | |a NYHA, New York Heart Association | |
650 | 4 | |a PAWP, pulmonary artery wedge pressure | |
650 | 4 | |a PH, pulmonary hypertension | |
650 | 4 | |a PVR, pulmonary vascular resistance | |
650 | 4 | |a RCM, restrictive cardiomyopathy | |
650 | 4 | |a atrial flow regulator device | |
650 | 4 | |a heart failure | |
650 | 4 | |a left atrial hypertension | |
650 | 4 | |a pulmonary hypertension | |
650 | 4 | |a pulmonary vascular disease | |
650 | 4 | |a restrictive cardiomyopathy | |
650 | 4 | |a transcatheter intervention | |
700 | 1 | |a Sabiniewicz, Anna |e verfasserin |4 aut | |
700 | 1 | |a Sabiniewicz, Robert |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t JACC. Case reports |d 2019 |g 4(2022), 14 vom: 20. Juli, Seite 878-884 |w (DE-627)NLM304093653 |x 2666-0849 |7 nnns |
773 | 1 | 8 | |g volume:4 |g year:2022 |g number:14 |g day:20 |g month:07 |g pages:878-884 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jaccas.2022.05.010 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 4 |j 2022 |e 14 |b 20 |c 07 |h 878-884 |